A20FMDV2

N/A

Report date: 2025/01/26 18:01:05

Base Information

Drug NameA20FMDV2
Drug Alias Nametoxin-conjugated A20FMDV2alpha-V/beta-6 binding peptide (Cancer Research Technology)A20FMDV2
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin alpha-V/beta-6 inhibitors
TargetsIntegrin alpha-V/beta-6
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesCancer Research UK
Inactive CompaniesCancer Research Technology
Active IndicationsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A